Modulight Oyj

US Tariffs And Delays Will Slow Progress Yet Unlock Potential

AnalystLowTarget

Not Invested

Consensus Narrative from 2 Analysts

Published

17 Aug 25

Updated

28 Aug 25

AnalystLowTarget's Fair Value

€1.60

13.1% undervalued

28 Aug

€1.39

17.8%

7.8%

17.8%

7.8%

Author's Valuation

€1.6

13.1% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

€1.6

13.1% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

28.08%

Medical Equipment revenue growth rate

0.45%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.31%

Calculation

€3.47m

Earnings '28

23.62x

PE Ratio '28

€81.87m

Market Cap '28

€81.87m

Market Cap '28

42.57m

No. shares '28

€1.92

Share Price '28

€1.92 Share Price '28

Discounted to 2025 @ 6.33% p.a.

€1.60

Fair Value '25